Who is sponsoring VitD-COVID19?

VitD-COVID19 is sponsored by Medical University of South Carolina.

What condition does VitD-COVID19 study?

VitD-COVID19 studies COVID-19, Vitamin D Deficiency, Respiratory Viral Infection.

What drugs are being tested in VitD-COVID19?

Interventions: Daily Vitamin D3, Daily placebo, Bolus vitamin D3, Bolus placebo.

What is the status of VitD-COVID19?

VitD-COVID19 is currently ACTIVE_NOT_RECRUITING.

Last reviewed 2023-02-24 · How we verify

Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection (VitD-COVID19)

NCT04482673 PHASE4 ACTIVE_NOT_RECRUITING

The purpose of this study is to evaluate how useful vitamin D supplementation is in reducing the severity of COVID-19 symptoms and the body's inflammatory and infection-fighting response to COVID-19. Individuals ≥50 years of age and older who are tested for COVID-19 and negative will be randomized (like flipping a coin) to either daily high dose vitamin D supplementation (6000 IU vitamin D3/day) vs. standard of care. Those individuals ≥50 years of age or older who test positive for COVID-19 at baseline will be randomized to bolus vitamin D (20,000 IU/day for 3 days) followed by high dose (6000 IU vitamin D/day) vs. standard of care for 12 months. All participants will receive a multivitamin containing vitamin D.

Details

Lead sponsor	Medical University of South Carolina
Phase	PHASE4
Status	ACTIVE_NOT_RECRUITING
Enrolment	95
Start date	Fri Jul 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Dec 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

COVID-19
Vitamin D Deficiency
Respiratory Viral Infection

Interventions

Daily Vitamin D3
Daily placebo
Bolus vitamin D3
Bolus placebo

Countries

United States